Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

6505--Levetiracetam Tablets

Awarded
36E79726R0001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract involves the procurement of Levetiracetam Tablets and related pharmaceutical products for the Department of Veterans Affairs, managed through the VA National Acquisition Center. The solicitation, numbered 36E79726R0001, was issued on November 12, 2025, with an initial offer due date of November 26, 2025. However, an amendment extended the deadline to December 3, 2025, at 2:30 PM Central Time, requiring offerors to include a signed copy of the amendment with their proposals. The procurement encompasses multiple dosage forms and packaging configurations, including bottles with safety caps and unit-of-use packaging, to be supplied over a base year with four optional renewal years, each with fixed quantities. The estimated annual quantities for each line item are specified, though prices are to be provided by offerors. The contract emphasizes strict compliance with packaging, labeling, and barcoding standards, including GS1-128, HIBCC, and ANSI/ISO/IEC Grade C quality for bar codes, with requirements for human-readable NDCs, lot numbers, expiration dates, and DSCSA serialization. Delivery is destination-based to government-designated distribution centers, with the period of performance to be determined at award. The solicitation references FAR clauses covering small business subcontracting, responsible contractor requirements, cybersecurity, and supply chain restrictions, including Buy American and foreign trade limitations. Evaluation will be based on Lowest Price Technically Acceptable criteria, considering non-cost factors such as technical compliance and past performance, with no specific weights or adjectival ratings disclosed. Offerors must submit proposals electronically via email, including completed SF-1449 forms, with no page limits specified, to designated VA email addresses before the deadline. Attachments include vendor and contractor information, along with relevant contractual and technical standards, ensuring products meet regulatory, safety, and traceability requirements throughout the supply chain.

General Info

Contract Value

$0

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

4

Amendment 0001 to Solicitation 36E79726R0001 - Extension of Offer Due Date

DOCX, High priority: read this first2 pages · amendment
High

Pre-Solicitation Notice for RFP 36E79726R0001 Levetiracetam Tablets

DOCX, High priority: read this first4 pages · presolicitation
High

Solicitation 36E79726R0001 for VA Pharmaceutical Supplies

DOCX, High priority: read this first82 pages · rfq
High

Award 36E79726D0019 - Levetiracetam Tablets

DOCX, Low priorityaward
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseAwarded
Posted

Presolicitation

Notice updated

The notice description changed.

Type Changed

Presolicitation → Solicitation

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → Nac Pharmaceuticals (36E797)
Contacts1 person available
OfficeHINES, IL, 60141, USA
Office AddressHINES, IL, 60141, USA
Contacts
Youlanda DuggarContract Specialist

Full Description

Show more
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=78926691bed0445dbbe5248722361b7b

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
6505--766-27-1-400-0021 -Charleston CMOP CALCIUM 500MG/VIT D 500UNIT CHEW TAB 90CT -(VA-27-00014312)
Solicitation # 36C77027Q0013
The Department of Veterans Affairs National CMOP Office is conducting market research through a Sources Sought notice to identify qualified sources for Calcium 500mg/Vitamin D 500unit chewable tablets in 90-count packaging. This effort is for market research purposes only and does not constitute a solicitation or an obligation to issue a contract. Interested vendors must submit their company point of contact, SAM Unique Entity ID, and a capability statement via email to the contract specialist by October 29, 2026. The anticipated requirement involves a total quantity of 3,200 packages, delivered in monthly increments of 800 units over four months, with the first delivery due 10 days after receipt of order. Products must be sourced directly from the Original Equipment Manufacturer and possess an FDA therapeutic equivalence code of A, unless all drugs in the family group are B rated. Technical requirements include a distinct eleven-digit National Drug Code for each product, a minimum shelf life of 12 months from delivery, and specific bottle dimensions of at least 100cc with a 5.75-inch circumference and child-safety caps for packages under 500 count. Strict packaging and labeling standards apply, requiring bar codes that conform to GS1-128 or HIBCC/HIBC standards with a minimum ANSI/ISO/IEC Quality Grade C. Bar codes must be placed on both the outside wrapper and the immediate container. Shipping documentation must include the VA Purchase Order and Obligation numbers, and products must be sorted by lot number, with only one lot per box. Invoicing will be handled by the VA Fiscal Service Center, and the invoice price must strictly match the purchase order price to avoid payment delays.
National Cmop Office (36C770)

POSTED

about 9 hours ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Veterans Affairs → Nac Pharmaceuticals (36E797)

Same awarding agency

NAICS: 325412
New
Federal
6505--Sacubitril/Valsartan Tablets (VA-27-00014055)
Solicitation # 36E79727R0007
The Department of Veterans Affairs Enterprise Procurement Office intends to award a single, unrestricted national mandatory requirements contract for an uninterrupted source of supply of Sacubitril-Valsartan Tablets. This procurement, issued under NAICS code 325412 and FAR Part 12, supports multiple federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract will span a one-year base period with four pre-priced one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs, requiring the contractor to execute necessary chargeback agreements to ensure timely delivery. The successful offeror must provide a unique eleven-digit National Drug Code (NDC) where the first five digits identify the offeror, and this must be the only label on the product. Strict packaging specifications are required for 60 and 180 count bottles, including a minimum volume of 120cc, a cylindrical body with at least a 5.75 inch circumference, and a safety cap that is either convertible or deshellable. Bottles must accommodate a 5.25 by 2 inch label with an additional 0.5 inch of space for barcodes and expiration data. Offerors who are not the manufacturer must provide a letter of commitment ensuring a sufficient source of supply. The solicitation is expected to be issued around December 18, 2026, with a tentative closing date of January 7, 2027.
Pharmaceutical Preparation Manufacturing

POSTED

4 days ago

DEADLINE

in 8 days
View Details
NAICS: 325412
Federal
6505--Imatinib Tablets
Solicitation # 36E79726R0036
The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.
Pharmaceutical Preparation Manufacturing

POSTED

10 days ago

DEADLINE

in 4 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS